Novel motif:165: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:26, 9 September 2013
name: | motif165_AAAGTTACTG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0048769 | sarcomerogenesis | 6.180471e-41 |
GO:0030240 | skeletal muscle thin filament assembly | 1.992041e-38 |
GO:0007076 | mitotic chromosome condensation | 1.778304e-34 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 1.138441e-32 |
GO:0014866 | skeletal myofibril assembly | 1.271491e-30 |
GO:0002576 | platelet degranulation | 7.156026e-29 |
GO:0055003 | cardiac myofibril assembly | 1.360458e-27 |
GO:0048739 | cardiac muscle fiber development | 2.390058e-26 |
GO:0045214 | sarcomere organization | 4.757149e-26 |
GO:0000070 | mitotic sister chromatid segregation | 2.079981e-24 |
GO:0030261 | chromosome condensation | 3.339408e-24 |
GO:0000819 | sister chromatid segregation | 4.328307e-24 |
GO:0048747 | muscle fiber development | 2.200248e-23 |
GO:0051592 | response to calcium ion | 2.629010e-22 |
GO:0006950 | response to stress | 2.512106e-21 |
GO:0006887 | exocytosis | 4.777707e-21 |
GO:0055013 | cardiac muscle cell development | 1.150011e-20 |
GO:0010038 | response to metal ion | 2.866197e-20 |
GO:0032940 | secretion by cell | 8.591258e-20 |
GO:0009611 | response to wounding | 9.698852e-20 |
GO:0006941 | striated muscle contraction | 2.605968e-19 |
GO:0010035 | response to inorganic substance | 4.832690e-19 |
GO:0042221 | response to chemical stimulus | 1.422733e-18 |
GO:0030168 | platelet activation | 4.237990e-18 |
GO:0030049 | muscle filament sliding | 7.534256e-18 |
GO:0070252 | actin-mediated cell contraction | 1.651626e-17 |
GO:0055008 | cardiac muscle tissue morphogenesis | 3.131634e-17 |
GO:0050896 | response to stimulus | 8.438134e-17 |
GO:0043623 | cellular protein complex assembly | 1.133688e-16 |
GO:0030239 | myofibril assembly | 1.493115e-16 |
GO:0046903 | secretion | 7.762982e-16 |
GO:0060415 | muscle tissue morphogenesis | 1.031470e-15 |
GO:0042060 | wound healing | 1.566637e-15 |
GO:0055002 | striated muscle cell development | 1.964042e-15 |
GO:0030048 | actin filament-based movement | 2.703008e-15 |
GO:0006810 | transport | 1.366080e-14 |
GO:0051234 | establishment of localization | 2.848235e-14 |
GO:0006323 | DNA packaging | 2.949544e-14 |
GO:0001775 | cell activation | 3.495313e-14 |
GO:0071103 | DNA conformation change | 1.410978e-13 |
GO:0031032 | actomyosin structure organization | 1.512813e-13 |
GO:0055001 | muscle cell development | 1.856307e-13 |
GO:0048644 | muscle organ morphogenesis | 2.482384e-13 |
GO:0010927 | cellular component assembly involved in morphogenesis | 3.181330e-13 |
GO:0051179 | localization | 4.002539e-13 |
GO:0034622 | cellular macromolecular complex assembly | 4.011800e-13 |
GO:0048729 | tissue morphogenesis | 6.899324e-13 |
GO:0003007 | heart morphogenesis | 7.421106e-13 |
GO:0016192 | vesicle-mediated transport | 1.129588e-12 |
GO:0035051 | cardiac cell differentiation | 1.781326e-12 |
GO:0014706 | striated muscle tissue development | 2.888956e-12 |
GO:0007596 | blood coagulation | 4.875448e-12 |
GO:0009653 | anatomical structure morphogenesis | 6.705273e-12 |
GO:0007599 | hemostasis | 7.065858e-12 |
GO:0065003 | macromolecular complex assembly | 1.377293e-11 |
GO:0007517 | muscle organ development | 2.162505e-11 |
GO:0055007 | cardiac muscle cell differentiation | 2.277533e-11 |
GO:0007015 | actin filament organization | 3.121550e-11 |
GO:0032501 | multicellular organismal process | 3.797464e-11 |
GO:0051649 | establishment of localization in cell | 5.176621e-11 |
GO:0006928 | cellular component movement | 5.641868e-11 |
GO:0060537 | muscle tissue development | 6.035641e-11 |
GO:0050878 | regulation of body fluid levels | 6.617319e-11 |
GO:0045175 | basal protein localization | 8.776575e-11 |
GO:0009888 | tissue development | 1.043372e-10 |
GO:0006749 | glutathione metabolic process | 1.557434e-10 |
GO:0051641 | cellular localization | 1.800321e-10 |
GO:0071702 | organic substance transport | 2.278495e-10 |
GO:0048856 | anatomical structure development | 2.960588e-10 |
GO:0048513 | organ development | 4.556345e-10 |
GO:0051146 | striated muscle cell differentiation | 4.693023e-10 |
GO:0006954 | inflammatory response | 5.005437e-10 |
GO:0034633 | retinol transport | 5.785216e-10 |
GO:0048468 | cell development | 6.078804e-10 |
GO:0009987 | cellular process | 8.168507e-10 |
GO:0043933 | macromolecular complex subunit organization | 9.900101e-10 |
GO:0006952 | defense response | 1.081767e-9 |
GO:0022607 | cellular component assembly | 1.097496e-9 |
GO:0006518 | peptide metabolic process | 2.066588e-9 |
GO:0065008 | regulation of biological quality | 2.219850e-9 |
GO:0072358 | cardiovascular system development | 2.288526e-9 |
GO:0032989 | cellular component morphogenesis | 2.703350e-9 |
GO:0007059 | chromosome segregation | 2.883835e-9 |
GO:0044085 | cellular component biogenesis | 2.918176e-9 |
GO:0034621 | cellular macromolecular complex subunit organization | 3.187500e-9 |
GO:0010885 | regulation of cholesterol storage | 3.253627e-9 |
GO:0008152 | metabolic process | 3.665261e-9 |
GO:0051450 | myoblast proliferation | 4.533429e-9 |
GO:0071844 | cellular component assembly at cellular level | 4.826093e-9 |
GO:0010269 | response to selenium ion | 5.339107e-9 |
GO:0042325 | regulation of phosphorylation | 6.985553e-9 |
GO:0016043 | cellular component organization | 7.905335e-9 |
GO:0002694 | regulation of leukocyte activation | 8.323208e-9 |
GO:0045540 | regulation of cholesterol biosynthetic process | 9.275394e-9 |
GO:0006449 | regulation of translational termination | 1.218120e-8 |
GO:0002376 | immune system process | 1.286286e-8 |
GO:0071840 | cellular component organization or biogenesis | 1.534240e-8 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 1.665835e-8 |
GO:0042572 | retinol metabolic process | 1.789242e-8 |
GO:0042574 | retinal metabolic process | 1.814117e-8 |
GO:0032502 | developmental process | 2.209799e-8 |
GO:0021509 | roof plate formation | 2.213707e-8 |
GO:0034377 | plasma lipoprotein particle assembly | 2.518321e-8 |
GO:0007507 | heart development | 2.676885e-8 |
GO:0014904 | myotube cell development | 3.103355e-8 |
GO:0044281 | small molecule metabolic process | 3.133411e-8 |
GO:0042692 | muscle cell differentiation | 3.535163e-8 |
GO:0071827 | plasma lipoprotein particle organization | 3.566137e-8 |
GO:0044238 | primary metabolic process | 3.682980e-8 |
GO:0044237 | cellular metabolic process | 4.458595e-8 |
GO:0072593 | reactive oxygen species metabolic process | 4.841312e-8 |
GO:0042398 | cellular modified amino acid biosynthetic process | 5.524508e-8 |
GO:0006869 | lipid transport | 5.534233e-8 |
GO:0065007 | biological regulation | 6.024877e-8 |
GO:0010743 | regulation of macrophage derived foam cell differentiation | 6.059136e-8 |
GO:0021527 | spinal cord association neuron differentiation | 6.096989e-8 |
GO:0000279 | M phase | 6.332499e-8 |
GO:0042327 | positive regulation of phosphorylation | 6.359125e-8 |
GO:0070271 | protein complex biogenesis | 7.751321e-8 |
GO:0002696 | positive regulation of leukocyte activation | 7.799656e-8 |
GO:0070887 | cellular response to chemical stimulus | 8.320499e-8 |
GO:0006461 | protein complex assembly | 9.884854e-8 |
GO:0090381 | regulation of heart induction | 9.899168e-8 |
GO:0007275 | multicellular organismal development | 1.155998e-7 |
GO:0048731 | system development | 1.252909e-7 |
GO:0051249 | regulation of lymphocyte activation | 1.299586e-7 |
GO:0050867 | positive regulation of cell activation | 1.366009e-7 |
GO:0034369 | plasma lipoprotein particle remodeling | 1.384220e-7 |
GO:0048869 | cellular developmental process | 1.479417e-7 |
GO:0050863 | regulation of T cell activation | 1.484881e-7 |
GO:0006775 | fat-soluble vitamin metabolic process | 1.486608e-7 |
GO:0033036 | macromolecule localization | 1.573098e-7 |
GO:0002684 | positive regulation of immune system process | 1.807616e-7 |
GO:0034374 | low-density lipoprotein particle remodeling | 1.922130e-7 |
GO:0070886 | positive regulation of calcineurin-NFAT signaling pathway | 1.979618e-7 |
GO:0048285 | organelle fission | 2.196527e-7 |
GO:0045905 | positive regulation of translational termination | 2.226665e-7 |
GO:0045901 | positive regulation of translational elongation | 2.226665e-7 |
GO:0006452 | translational frameshifting | 2.226665e-7 |
GO:0050865 | regulation of cell activation | 2.339609e-7 |
GO:0001932 | regulation of protein phosphorylation | 2.856983e-7 |
GO:0071681 | cellular response to indole-3-methanol | 2.956721e-7 |
GO:0001934 | positive regulation of protein phosphorylation | 3.185271e-7 |
GO:0030154 | cell differentiation | 3.363848e-7 |
GO:0010883 | regulation of lipid storage | 3.494863e-7 |
GO:0006790 | sulfur compound metabolic process | 3.723934e-7 |
GO:0071731 | response to nitric oxide | 3.791888e-7 |
GO:0003006 | developmental process involved in reproduction | 4.068282e-7 |
GO:0045937 | positive regulation of phosphate metabolic process | 4.142126e-7 |
GO:0009605 | response to external stimulus | 5.143861e-7 |
GO:0006776 | vitamin A metabolic process | 5.427313e-7 |
GO:0009791 | post-embryonic development | 5.541026e-7 |
GO:0019220 | regulation of phosphate metabolic process | 5.603123e-7 |
GO:0009887 | organ morphogenesis | 5.908986e-7 |
GO:0071842 | cellular component organization at cellular level | 6.391704e-7 |
GO:0010744 | positive regulation of macrophage derived foam cell differentiation | 6.614123e-7 |
GO:0010033 | response to organic substance | 6.724424e-7 |
GO:0048738 | cardiac muscle tissue development | 7.524003e-7 |
GO:0045627 | positive regulation of T-helper 1 cell differentiation | 8.029826e-7 |
GO:0048854 | brain morphogenesis | 8.673729e-7 |
GO:0008105 | asymmetric protein localization | 8.900750e-7 |
GO:0010876 | lipid localization | 1.031678e-6 |
GO:0032743 | positive regulation of interleukin-2 production | 1.073894e-6 |
GO:0050789 | regulation of biological process | 1.090111e-6 |
GO:0051246 | regulation of protein metabolic process | 1.101434e-6 |
GO:0003308 | negative regulation of Wnt receptor signaling pathway involved in heart development | 1.137221e-6 |
GO:0032944 | regulation of mononuclear cell proliferation | 1.228317e-6 |
GO:0033993 | response to lipid | 1.325826e-6 |
GO:0006259 | DNA metabolic process | 1.367780e-6 |
GO:0015918 | sterol transport | 1.392244e-6 |
GO:0010886 | positive regulation of cholesterol storage | 1.515742e-6 |
GO:0032787 | monocarboxylic acid metabolic process | 1.641107e-6 |
GO:0003307 | regulation of Wnt receptor signaling pathway involved in heart development | 1.668912e-6 |
GO:0046464 | acylglycerol catabolic process | 1.738090e-6 |
GO:0007067 | mitosis | 1.744323e-6 |
GO:0060396 | growth hormone receptor signaling pathway | 1.782847e-6 |
GO:0043129 | surfactant homeostasis | 1.782847e-6 |
GO:0006936 | muscle contraction | 1.856252e-6 |
GO:0003350 | pulmonary myocardium development | 1.872868e-6 |
GO:0050670 | regulation of lymphocyte proliferation | 1.881348e-6 |
GO:0043931 | ossification involved in bone maturation | 2.104232e-6 |
GO:0071841 | cellular component organization or biogenesis at cellular level | 2.158164e-6 |
GO:0070884 | regulation of calcineurin-NFAT signaling pathway | 2.194155e-6 |
GO:0048630 | skeletal muscle tissue growth | 2.231564e-6 |
GO:0043043 | peptide biosynthetic process | 2.266489e-6 |
GO:0071732 | cellular response to nitric oxide | 2.267390e-6 |
GO:0046621 | negative regulation of organ growth | 2.282035e-6 |
GO:0006807 | nitrogen compound metabolic process | 2.319744e-6 |
GO:0070741 | response to interleukin-6 | 2.329037e-6 |
GO:0002682 | regulation of immune system process | 2.390863e-6 |
GO:0030301 | cholesterol transport | 2.590709e-6 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 2.666761e-6 |
GO:0009441 | glycolate metabolic process | 2.682877e-6 |
GO:0034614 | cellular response to reactive oxygen species | 2.768496e-6 |
GO:0090181 | regulation of cholesterol metabolic process | 2.816696e-6 |
GO:0000087 | M phase of mitotic cell cycle | 3.177381e-6 |
GO:0051716 | cellular response to stimulus | 3.276593e-6 |
GO:0008104 | protein localization | 3.294809e-6 |
GO:0031399 | regulation of protein modification process | 3.341816e-6 |
GO:0034379 | very-low-density lipoprotein particle assembly | 3.692160e-6 |
GO:0061061 | muscle structure development | 3.959564e-6 |
GO:0030070 | insulin processing | 4.014979e-6 |
GO:0006642 | triglyceride mobilization | 4.067635e-6 |
GO:0051251 | positive regulation of lymphocyte activation | 4.098596e-6 |
GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep | 4.335433e-6 |
GO:0009147 | pyrimidine nucleoside triphosphate metabolic process | 4.383769e-6 |
GO:0032270 | positive regulation of cellular protein metabolic process | 4.393208e-6 |
GO:0006750 | glutathione biosynthetic process | 4.405661e-6 |
GO:0033700 | phospholipid efflux | 4.619851e-6 |
GO:0015031 | protein transport | 4.841852e-6 |
GO:0009820 | alkaloid metabolic process | 4.913140e-6 |
GO:0008612 | peptidyl-lysine modification to hypusine | 4.933228e-6 |
GO:0046620 | regulation of organ growth | 5.640228e-6 |
GO:0050830 | defense response to Gram-positive bacterium | 5.852032e-6 |
GO:0051247 | positive regulation of protein metabolic process | 5.972102e-6 |
GO:0006629 | lipid metabolic process | 6.001767e-6 |
GO:0045776 | negative regulation of blood pressure | 6.169061e-6 |
GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep | 6.222103e-6 |
GO:0003012 | muscle system process | 6.659704e-6 |
GO:0090096 | positive regulation of metanephric cap mesenchymal cell proliferation | 6.673076e-6 |
GO:0071379 | cellular response to prostaglandin stimulus | 6.844078e-6 |
GO:0050908 | detection of light stimulus involved in visual perception | 6.934309e-6 |
GO:0035020 | regulation of Rac protein signal transduction | 7.038802e-6 |
GO:0034641 | cellular nitrogen compound metabolic process | 7.424832e-6 |
GO:2000620 | positive regulation of histone H4-K16 acetylation | 7.546228e-6 |
GO:0070512 | positive regulation of histone H4-K20 methylation | 7.546228e-6 |
GO:2000617 | positive regulation of histone H3-K9 acetylation | 7.546228e-6 |
GO:0021516 | dorsal spinal cord development | 7.918693e-6 |
GO:0010884 | positive regulation of lipid storage | 8.384845e-6 |
GO:0045184 | establishment of protein localization | 8.447335e-6 |
GO:0006691 | leukotriene metabolic process | 8.683519e-6 |
GO:0071822 | protein complex subunit organization | 9.305299e-6 |
GO:0007049 | cell cycle | 9.743158e-6 |
GO:0033483 | gas homeostasis | 1.005143e-5 |
GO:0033344 | cholesterol efflux | 1.072167e-5 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 1.075745e-5 |
GO:0046105 | thymidine biosynthetic process | 1.106582e-5 |
GO:0042953 | lipoprotein transport | 1.222234e-5 |
GO:0042987 | amyloid precursor protein catabolic process | 1.231303e-5 |
GO:0006746 | FADH2 metabolic process | 1.252089e-5 |
GO:0008206 | bile acid metabolic process | 1.263527e-5 |
GO:0060056 | mammary gland involution | 1.297282e-5 |
GO:0032268 | regulation of cellular protein metabolic process | 1.361990e-5 |
GO:0046394 | carboxylic acid biosynthetic process | 1.393763e-5 |
GO:0031401 | positive regulation of protein modification process | 1.415839e-5 |
GO:0009120 | deoxyribonucleoside metabolic process | 1.445561e-5 |
GO:0022612 | gland morphogenesis | 1.466142e-5 |
GO:0031334 | positive regulation of protein complex assembly | 1.479954e-5 |
GO:0060416 | response to growth hormone stimulus | 1.485951e-5 |
GO:0070977 | bone maturation | 1.517645e-5 |
GO:0001523 | retinoid metabolic process | 1.536920e-5 |
GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep | 1.540064e-5 |
GO:0034063 | stress granule assembly | 1.647157e-5 |
GO:0009410 | response to xenobiotic stimulus | 1.678851e-5 |
GO:0048853 | forebrain morphogenesis | 1.710150e-5 |
GO:0006898 | receptor-mediated endocytosis | 1.720283e-5 |
GO:0006213 | pyrimidine nucleoside metabolic process | 1.760338e-5 |
GO:0006516 | glycoprotein catabolic process | 1.762254e-5 |
GO:0051276 | chromosome organization | 1.819069e-5 |
GO:0070663 | regulation of leukocyte proliferation | 1.824311e-5 |
GO:0090066 | regulation of anatomical structure size | 1.867104e-5 |
GO:0019433 | triglyceride catabolic process | 2.026755e-5 |
GO:0010828 | positive regulation of glucose transport | 2.073640e-5 |
GO:0040007 | growth | 2.091217e-5 |
GO:0032314 | regulation of Rac GTPase activity | 2.113286e-5 |
GO:0045760 | positive regulation of action potential | 2.186922e-5 |
GO:0035229 | positive regulation of glutamate-cysteine ligase activity | 2.274524e-5 |
GO:0042493 | response to drug | 2.364659e-5 |
GO:0051883 | killing of cells in other organism involved in symbiotic interaction | 2.465875e-5 |
GO:0046503 | glycerolipid catabolic process | 2.530653e-5 |
GO:0033962 | cytoplasmic mRNA processing body assembly | 2.571672e-5 |
GO:0019430 | removal of superoxide radicals | 2.618791e-5 |
GO:0051704 | multi-organism process | 2.775184e-5 |
GO:0044283 | small molecule biosynthetic process | 2.843701e-5 |
GO:0006721 | terpenoid metabolic process | 2.903317e-5 |
GO:0007281 | germ cell development | 2.965840e-5 |
GO:0034587 | piRNA metabolic process | 2.971149e-5 |
GO:0034599 | cellular response to oxidative stress | 3.021841e-5 |
GO:0032273 | positive regulation of protein polymerization | 3.096059e-5 |
GO:0071466 | cellular response to xenobiotic stimulus | 3.163636e-5 |
GO:0019852 | L-ascorbic acid metabolic process | 3.214219e-5 |
GO:0008203 | cholesterol metabolic process | 3.247154e-5 |
GO:0048518 | positive regulation of biological process | 3.365014e-5 |
GO:0050435 | beta-amyloid metabolic process | 3.385639e-5 |
GO:0042632 | cholesterol homeostasis | 3.404604e-5 |
GO:0090199 | regulation of release of cytochrome c from mitochondria | 3.491469e-5 |
GO:0042743 | hydrogen peroxide metabolic process | 3.515061e-5 |
GO:0048554 | positive regulation of metalloenzyme activity | 3.632331e-5 |
GO:0044255 | cellular lipid metabolic process | 3.852344e-5 |
GO:0001889 | liver development | 4.077559e-5 |
GO:0032663 | regulation of interleukin-2 production | 4.278160e-5 |
GO:0035630 | bone mineralization involved in bone maturation | 4.295228e-5 |
GO:0071396 | cellular response to lipid | 4.477528e-5 |
GO:0031295 | T cell costimulation | 4.545716e-5 |
GO:0050672 | negative regulation of lymphocyte proliferation | 4.626101e-5 |
GO:0055072 | iron ion homeostasis | 4.653168e-5 |
GO:0045187 | regulation of circadian sleep/wake cycle, sleep | 4.731385e-5 |
GO:0070286 | axonemal dynein complex assembly | 4.853642e-5 |
GO:0034383 | low-density lipoprotein particle clearance | 4.996571e-5 |
GO:0048807 | female genitalia morphogenesis | 5.024418e-5 |
GO:0034123 | positive regulation of toll-like receptor signaling pathway | 5.037110e-5 |
GO:0007584 | response to nutrient | 5.064197e-5 |
GO:0042659 | regulation of cell fate specification | 5.300994e-5 |
GO:0034381 | plasma lipoprotein particle clearance | 5.410181e-5 |
GO:0051659 | maintenance of mitochondrion location | 5.612757e-5 |
GO:0061008 | hepaticobiliary system development | 5.680712e-5 |
GO:0016101 | diterpenoid metabolic process | 5.781112e-5 |
GO:0006953 | acute-phase response | 5.862329e-5 |
GO:0019370 | leukotriene biosynthetic process | 5.877116e-5 |
GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway | 5.902794e-5 |
GO:0043412 | macromolecule modification | 5.942304e-5 |
GO:0070849 | response to epidermal growth factor stimulus | 6.011091e-5 |
GO:0070541 | response to platinum ion | 6.687277e-5 |
GO:0050880 | regulation of blood vessel size | 6.776765e-5 |
GO:0051657 | maintenance of organelle location | 7.072701e-5 |
GO:0045629 | negative regulation of T-helper 2 cell differentiation | 7.072701e-5 |
GO:0006805 | xenobiotic metabolic process | 7.224879e-5 |
GO:0071223 | cellular response to lipoteichoic acid | 7.427530e-5 |
GO:0060068 | vagina development | 7.524647e-5 |
GO:2000409 | positive regulation of T cell extravasation | 7.660033e-5 |
GO:0043310 | negative regulation of eosinophil degranulation | 7.660033e-5 |
GO:0035696 | monocyte extravasation | 7.660033e-5 |
GO:0035705 | T-helper 17 cell chemotaxis | 7.660033e-5 |
GO:0090082 | positive regulation of heart induction by negative regulation of canonical Wnt receptor signaling pathway | 7.730923e-5 |
GO:0022410 | circadian sleep/wake cycle process | 7.741362e-5 |
GO:0035150 | regulation of tube size | 7.882492e-5 |
GO:0034097 | response to cytokine stimulus | 8.267898e-5 |
GO:0034392 | negative regulation of smooth muscle cell apoptosis | 8.334325e-5 |
GO:0006448 | regulation of translational elongation | 8.334325e-5 |
GO:0006982 | response to lipid hydroperoxide | 8.334325e-5 |
GO:0016125 | sterol metabolic process | 8.441966e-5 |
GO:0051591 | response to cAMP | 8.526096e-5 |
GO:0002526 | acute inflammatory response | 9.070395e-5 |
GO:0007622 | rhythmic behavior | 9.247019e-5 |
GO:0015812 | gamma-aminobutyric acid transport | 9.508184e-5 |
GO:0042159 | lipoprotein catabolic process | 9.625695e-5 |
GO:0050870 | positive regulation of T cell activation | 9.653318e-5 |
GO:0009719 | response to endogenous stimulus | 9.744620e-5 |
GO:0050794 | regulation of cellular process | 1.025079e-4 |
GO:0090239 | regulation of histone H4 acetylation | 1.058180e-4 |
GO:0009584 | detection of visible light | 1.183805e-4 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt receptor signaling pathway | 1.204729e-4 |
GO:0050868 | negative regulation of T cell activation | 1.226263e-4 |
GO:0045625 | regulation of T-helper 1 cell differentiation | 1.238720e-4 |
GO:0042745 | circadian sleep/wake cycle | 1.238741e-4 |
GO:0030573 | bile acid catabolic process | 1.247494e-4 |
GO:0046086 | adenosine biosynthetic process | 1.247530e-4 |
GO:0006699 | bile acid biosynthetic process | 1.257768e-4 |
GO:0042180 | cellular ketone metabolic process | 1.268254e-4 |
GO:0009582 | detection of abiotic stimulus | 1.303876e-4 |
GO:0034014 | response to triglyceride | 1.311441e-4 |
GO:0007276 | gamete generation | 1.321371e-4 |
GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process | 1.330818e-4 |
GO:0055088 | lipid homeostasis | 1.331130e-4 |
GO:0006886 | intracellular protein transport | 1.366704e-4 |
GO:0030317 | sperm motility | 1.482014e-4 |
GO:0032364 | oxygen homeostasis | 1.505365e-4 |
GO:0060442 | branching involved in prostate gland morphogenesis | 1.512057e-4 |
GO:0048584 | positive regulation of response to stimulus | 1.587523e-4 |
GO:0045768 | positive regulation of anti-apoptosis | 1.600743e-4 |
GO:0030277 | maintenance of gastrointestinal epithelium | 1.605070e-4 |
GO:0006801 | superoxide metabolic process | 1.672565e-4 |
GO:0042127 | regulation of cell proliferation | 1.680338e-4 |
GO:0051606 | detection of stimulus | 1.681066e-4 |
GO:0072387 | flavin adenine dinucleotide metabolic process | 1.703847e-4 |
GO:0035644 | phosphoanandamide dephosphorylation | 1.703847e-4 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 1.719786e-4 |
GO:0010155 | regulation of proton transport | 1.719786e-4 |
GO:0051024 | positive regulation of immunoglobulin secretion | 1.725855e-4 |
GO:0009200 | deoxyribonucleoside triphosphate metabolic process | 1.731770e-4 |
GO:0050790 | regulation of catalytic activity | 1.786519e-4 |
GO:0051180 | vitamin transport | 1.842575e-4 |
GO:0046104 | thymidine metabolic process | 1.869487e-4 |
GO:0003136 | negative regulation of heart induction by canonical Wnt receptor signaling pathway | 1.869487e-4 |
GO:0042129 | regulation of T cell proliferation | 1.881563e-4 |
GO:0019752 | carboxylic acid metabolic process | 1.918550e-4 |
GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 1.955779e-4 |
GO:0006139 | nucleobase-containing compound metabolic process | 1.983888e-4 |
GO:0032374 | regulation of cholesterol transport | 2.008638e-4 |
GO:0045767 | regulation of anti-apoptosis | 2.011156e-4 |
GO:0001706 | endoderm formation | 2.109681e-4 |
GO:0046326 | positive regulation of glucose import | 2.145013e-4 |
GO:0051250 | negative regulation of lymphocyte activation | 2.201874e-4 |
GO:0006082 | organic acid metabolic process | 2.216673e-4 |
GO:0060333 | interferon-gamma-mediated signaling pathway | 2.260417e-4 |
GO:0032924 | activin receptor signaling pathway | 2.377432e-4 |
GO:0010872 | regulation of cholesterol esterification | 2.427711e-4 |
GO:0060741 | prostate gland stromal morphogenesis | 2.436527e-4 |
GO:0044242 | cellular lipid catabolic process | 2.472280e-4 |
GO:0048512 | circadian behavior | 2.485637e-4 |
GO:0071826 | ribonucleoprotein complex subunit organization | 2.493170e-4 |
GO:0014051 | gamma-aminobutyric acid secretion | 2.515828e-4 |
GO:0006552 | leucine catabolic process | 2.515828e-4 |
GO:0006768 | biotin metabolic process | 2.515828e-4 |
GO:0050760 | negative regulation of thymidylate synthase biosynthetic process | 2.539003e-4 |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 2.608143e-4 |
GO:0032878 | regulation of establishment or maintenance of cell polarity | 2.628088e-4 |
GO:0034694 | response to prostaglandin stimulus | 2.648229e-4 |
GO:0019953 | sexual reproduction | 2.701788e-4 |
GO:0009581 | detection of external stimulus | 2.903349e-4 |
GO:0009743 | response to carbohydrate stimulus | 2.907235e-4 |
GO:0060249 | anatomical structure homeostasis | 2.914058e-4 |
GO:0019217 | regulation of fatty acid metabolic process | 2.945097e-4 |
GO:0007585 | respiratory gaseous exchange | 2.977136e-4 |
GO:0006796 | phosphate-containing compound metabolic process | 3.001653e-4 |
GO:0034754 | cellular hormone metabolic process | 3.048213e-4 |
GO:0002384 | hepatic immune response | 3.081570e-4 |
GO:0022402 | cell cycle process | 3.119711e-4 |
GO:0006720 | isoprenoid metabolic process | 3.157508e-4 |
GO:0009991 | response to extracellular stimulus | 3.200767e-4 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 3.215946e-4 |
GO:0060527 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | 3.291767e-4 |
GO:0010824 | regulation of centrosome duplication | 3.307799e-4 |
GO:0071354 | cellular response to interleukin-6 | 3.356560e-4 |
GO:0000303 | response to superoxide | 3.356560e-4 |
GO:0002238 | response to molecule of fungal origin | 3.410560e-4 |
GO:0019372 | lipoxygenase pathway | 3.517628e-4 |
GO:0030036 | actin cytoskeleton organization | 3.696809e-4 |
GO:0043254 | regulation of protein complex assembly | 3.703656e-4 |
GO:0046219 | indolalkylamine biosynthetic process | 3.712524e-4 |
GO:0046687 | response to chromate | 3.712524e-4 |
GO:0033986 | response to methanol | 3.712524e-4 |
GO:0016477 | cell migration | 3.762889e-4 |
GO:0060749 | mammary gland alveolus development | 3.841621e-4 |
GO:0002695 | negative regulation of leukocyte activation | 3.924158e-4 |
GO:0010887 | negative regulation of cholesterol storage | 3.933807e-4 |
GO:0001662 | behavioral fear response | 4.009971e-4 |
GO:0043306 | positive regulation of mast cell degranulation | 4.019953e-4 |
GO:0010459 | negative regulation of heart rate | 4.040208e-4 |
GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 4.087671e-4 |
GO:0022414 | reproductive process | 4.129776e-4 |
GO:0033577 | protein glycosylation in endoplasmic reticulum | 4.138852e-4 |
GO:0009726 | detection of endogenous stimulus | 4.213517e-4 |
GO:0019538 | protein metabolic process | 4.224227e-4 |
GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway | 4.225184e-4 |
GO:0019836 | hemolysis by symbiont of host erythrocytes | 4.225184e-4 |
GO:0043046 | DNA methylation involved in gamete generation | 4.301418e-4 |
GO:0006654 | phosphatidic acid biosynthetic process | 4.320463e-4 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 4.474862e-4 |
GO:0042522 | regulation of tyrosine phosphorylation of Stat5 protein | 4.629116e-4 |
GO:0048523 | negative regulation of cellular process | 4.660179e-4 |
GO:0048534 | hemopoietic or lymphoid organ development | 4.702682e-4 |
GO:0071398 | cellular response to fatty acid | 4.800288e-4 |
GO:0009612 | response to mechanical stimulus | 4.801836e-4 |
GO:0006665 | sphingolipid metabolic process | 4.809162e-4 |
GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling | 4.956281e-4 |
GO:0043603 | cellular amide metabolic process | 5.003823e-4 |
GO:0022618 | ribonucleoprotein complex assembly | 5.083469e-4 |
GO:0000305 | response to oxygen radical | 5.215559e-4 |
GO:0031998 | regulation of fatty acid beta-oxidation | 5.225306e-4 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | 5.230023e-4 |
GO:0002209 | behavioral defense response | 5.244940e-4 |
GO:0051000 | positive regulation of nitric-oxide synthase activity | 5.321003e-4 |
GO:0046473 | phosphatidic acid metabolic process | 5.448929e-4 |
GO:0010656 | negative regulation of muscle cell apoptosis | 5.489861e-4 |
GO:0050709 | negative regulation of protein secretion | 5.515065e-4 |
GO:0048522 | positive regulation of cellular process | 5.544352e-4 |
GO:0000042 | protein targeting to Golgi | 5.555523e-4 |
GO:0010821 | regulation of mitochondrion organization | 5.578047e-4 |
GO:0042982 | amyloid precursor protein metabolic process | 5.584850e-4 |
GO:0002683 | negative regulation of immune system process | 5.585809e-4 |
GO:0033632 | regulation of cell-cell adhesion mediated by integrin | 5.672421e-4 |
GO:0061316 | canonical Wnt receptor signaling pathway involved in heart development | 5.876695e-4 |
GO:0090304 | nucleic acid metabolic process | 5.892708e-4 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 5.905306e-4 |
GO:0033194 | response to hydroperoxide | 5.950767e-4 |
GO:0045542 | positive regulation of cholesterol biosynthetic process | 5.964911e-4 |
GO:0007166 | cell surface receptor linked signaling pathway | 6.078384e-4 |
GO:0000003 | reproduction | 6.244558e-4 |
GO:0010875 | positive regulation of cholesterol efflux | 6.246649e-4 |
GO:0046716 | muscle cell homeostasis | 6.297302e-4 |
GO:0010722 | regulation of ferrochelatase activity | 6.330391e-4 |
GO:0001764 | neuron migration | 6.541861e-4 |
GO:0045824 | negative regulation of innate immune response | 6.567381e-4 |
GO:0048609 | multicellular organismal reproductive process | 6.614244e-4 |
GO:0006955 | immune response | 6.664611e-4 |
GO:0060571 | morphogenesis of an epithelial fold | 6.676364e-4 |
GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 6.859699e-4 |
GO:0045087 | innate immune response | 6.973322e-4 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 7.022549e-4 |
GO:0034205 | beta-amyloid formation | 7.167351e-4 |
GO:0000188 | inactivation of MAPK activity | 7.199897e-4 |
GO:0009725 | response to hormone stimulus | 7.306378e-4 |
GO:0002829 | negative regulation of type 2 immune response | 7.336264e-4 |
GO:0046942 | carboxylic acid transport | 7.467574e-4 |
GO:0010453 | regulation of cell fate commitment | 7.499463e-4 |
GO:0006730 | one-carbon metabolic process | 7.508122e-4 |
GO:0009617 | response to bacterium | 7.528541e-4 |
GO:0034021 | response to silicon dioxide | 7.578789e-4 |
GO:0048773 | erythrophore differentiation | 7.578789e-4 |
GO:0003069 | vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure | 7.578789e-4 |
GO:0001315 | age-dependent response to reactive oxygen species | 7.578789e-4 |
GO:0006690 | icosanoid metabolic process | 7.612354e-4 |
GO:0050665 | hydrogen peroxide biosynthetic process | 7.680730e-4 |
GO:0007172 | signal complex assembly | 7.716333e-4 |
GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 7.765528e-4 |
GO:0050776 | regulation of immune response | 7.812686e-4 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 7.911724e-4 |
GO:0046939 | nucleotide phosphorylation | 7.913958e-4 |
GO:0033273 | response to vitamin | 7.921432e-4 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0010269 | response to selenium ion | 1.286976e-11 |
GO:0055003 | cardiac myofibril assembly | 3.141070e-11 |
GO:0042759 | long-chain fatty acid biosynthetic process | 7.475474e-11 |
GO:0031032 | actomyosin structure organization | 3.147968e-10 |
GO:0030239 | myofibril assembly | 1.119223e-9 |
GO:0006278 | RNA-dependent DNA replication | 1.069689e-8 |
GO:0022010 | central nervous system myelination | 1.705126e-8 |
GO:0007608 | sensory perception of smell | 1.908551e-8 |
GO:0007512 | adult heart development | 2.605322e-8 |
GO:0050911 | detection of chemical stimulus involved in sensory perception of smell | 3.313184e-8 |
GO:0043056 | forward locomotion | 4.034688e-8 |
GO:0033058 | directional locomotion | 6.788063e-8 |
GO:0055013 | cardiac muscle cell development | 8.894121e-8 |
GO:0046835 | carbohydrate phosphorylation | 9.853542e-8 |
GO:0045214 | sarcomere organization | 1.415318e-7 |
GO:0051259 | protein oligomerization | 1.702034e-7 |
GO:0018924 | mandelate metabolic process | 1.731830e-7 |
GO:0009268 | response to pH | 2.328904e-7 |
GO:0055006 | cardiac cell development | 2.418818e-7 |
GO:0051496 | positive regulation of stress fiber assembly | 3.079531e-7 |
GO:0010927 | cellular component assembly involved in morphogenesis | 4.617950e-7 |
GO:0031424 | keratinization | 5.888590e-7 |
GO:0018149 | peptide cross-linking | 7.766692e-7 |
GO:0033133 | positive regulation of glucokinase activity | 9.281516e-7 |
GO:0006952 | defense response | 1.481529e-6 |
GO:0030029 | actin filament-based process | 1.623531e-6 |
GO:0006950 | response to stress | 2.096713e-6 |
GO:0050907 | detection of chemical stimulus involved in sensory perception | 2.271756e-6 |
GO:0030048 | actin filament-based movement | 3.125728e-6 |
GO:0055002 | striated muscle cell development | 3.136320e-6 |
GO:0050896 | response to stimulus | 3.474988e-6 |
GO:0046373 | L-arabinose metabolic process | 3.639714e-6 |
GO:0030595 | leukocyte chemotaxis | 3.918242e-6 |
GO:0006518 | peptide metabolic process | 4.172579e-6 |
GO:0005996 | monosaccharide metabolic process | 4.213424e-6 |
GO:0007600 | sensory perception | 5.165677e-6 |
GO:0050892 | intestinal absorption | 5.229656e-6 |
GO:0032233 | positive regulation of actin filament bundle assembly | 5.230901e-6 |
GO:0006633 | fatty acid biosynthetic process | 5.691079e-6 |
GO:0001676 | long-chain fatty acid metabolic process | 6.544533e-6 |
GO:0043403 | skeletal muscle tissue regeneration | 8.027086e-6 |
GO:0001887 | selenium compound metabolic process | 8.810612e-6 |
GO:0050688 | regulation of defense response to virus | 9.797839e-6 |
GO:0045091 | regulation of retroviral genome replication | 1.070006e-5 |
GO:0010155 | regulation of proton transport | 1.236226e-5 |
GO:0006924 | activation-induced cell death of T cells | 1.288752e-5 |
GO:0007057 | spindle assembly involved in female meiosis I | 1.332674e-5 |
GO:0033131 | regulation of glucokinase activity | 1.909341e-5 |
GO:0045346 | regulation of MHC class II biosynthetic process | 2.156925e-5 |
GO:0070206 | protein trimerization | 2.202769e-5 |
GO:0002268 | follicular dendritic cell differentiation | 2.258200e-5 |
GO:0006091 | generation of precursor metabolites and energy | 3.168993e-5 |
GO:0071670 | smooth muscle cell chemotaxis | 3.268379e-5 |
GO:0060981 | cell migration involved in coronary angiogenesis | 3.268379e-5 |
GO:0046365 | monosaccharide catabolic process | 3.332585e-5 |
GO:0072012 | glomerulus vasculature development | 3.626271e-5 |
GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 3.862575e-5 |
GO:0051248 | negative regulation of protein metabolic process | 3.918060e-5 |
GO:0006096 | glycolysis | 4.184510e-5 |
GO:0006007 | glucose catabolic process | 4.404745e-5 |
GO:0060537 | muscle tissue development | 4.458779e-5 |
GO:0050906 | detection of stimulus involved in sensory perception | 4.720073e-5 |
GO:0050687 | negative regulation of defense response to virus | 4.985228e-5 |
GO:0055001 | muscle cell development | 5.006240e-5 |
GO:0014706 | striated muscle tissue development | 5.108236e-5 |
GO:0060292 | long term synaptic depression | 5.681778e-5 |
GO:0002238 | response to molecule of fungal origin | 5.942590e-5 |
GO:0048469 | cell maturation | 6.309656e-5 |
GO:2000320 | negative regulation of T-helper 17 cell differentiation | 6.341395e-5 |
GO:0019320 | hexose catabolic process | 6.549828e-5 |
GO:0072104 | glomerular capillary formation | 6.622958e-5 |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 7.020875e-5 |
GO:0030036 | actin cytoskeleton organization | 7.244546e-5 |
GO:0051492 | regulation of stress fiber assembly | 7.429582e-5 |
GO:0019321 | pentose metabolic process | 7.446382e-5 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 7.737034e-5 |
GO:0042221 | response to chemical stimulus | 8.088744e-5 |
GO:0030050 | vesicle transport along actin filament | 8.089499e-5 |
GO:2000685 | positive regulation of cellular response to X-ray | 8.378279e-5 |
GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining | 8.378279e-5 |
GO:2001038 | regulation of cellular response to drug | 8.378279e-5 |
GO:0035988 | chondrocyte proliferation | 8.378279e-5 |
GO:0035978 | histone H2A-S139 phosphorylation | 8.378279e-5 |
GO:0031052 | chromosome breakage | 8.378279e-5 |
GO:0003131 | mesodermal-endodermal cell signaling | 8.378279e-5 |
GO:0033299 | secretion of lysosomal enzymes | 8.378279e-5 |
GO:0055114 | oxidation-reduction process | 8.742989e-5 |
GO:0072109 | glomerular mesangium development | 9.139688e-5 |
GO:0042989 | sequestering of actin monomers | 9.335066e-5 |
GO:0044281 | small molecule metabolic process | 9.769002e-5 |
GO:0051262 | protein tetramerization | 9.775180e-5 |
GO:0009913 | epidermal cell differentiation | 1.022678e-4 |
GO:0008016 | regulation of heart contraction | 1.027435e-4 |
GO:0040011 | locomotion | 1.029408e-4 |
GO:0045869 | negative regulation of retroviral genome replication | 1.077773e-4 |
GO:0060326 | cell chemotaxis | 1.169086e-4 |
GO:0042743 | hydrogen peroxide metabolic process | 1.178058e-4 |
GO:0002026 | regulation of the force of heart contraction | 1.218464e-4 |
GO:0070227 | lymphocyte apoptosis | 1.226821e-4 |
GO:0007517 | muscle organ development | 1.230043e-4 |
GO:0051260 | protein homooligomerization | 1.277498e-4 |
GO:0048738 | cardiac muscle tissue development | 1.303641e-4 |
GO:0070207 | protein homotrimerization | 1.329840e-4 |
GO:0035019 | somatic stem cell maintenance | 1.420657e-4 |
GO:0030216 | keratinocyte differentiation | 1.508989e-4 |
GO:0010625 | positive regulation of Schwann cell proliferation | 1.511481e-4 |
GO:0019233 | sensory perception of pain | 1.572453e-4 |
GO:0048818 | positive regulation of hair follicle maturation | 1.585196e-4 |
GO:0046782 | regulation of viral transcription | 1.661896e-4 |
GO:0055007 | cardiac muscle cell differentiation | 1.778670e-4 |
GO:0015760 | glucose-6-phosphate transport | 1.788366e-4 |
GO:2000319 | regulation of T-helper 17 cell differentiation | 1.810688e-4 |
GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase | 1.810688e-4 |
GO:0051384 | response to glucocorticoid stimulus | 1.823509e-4 |
GO:0032956 | regulation of actin cytoskeleton organization | 1.830464e-4 |
GO:0033135 | regulation of peptidyl-serine phosphorylation | 1.833560e-4 |
GO:0051606 | detection of stimulus | 1.875163e-4 |
GO:0042637 | catagen | 1.954198e-4 |
GO:0061061 | muscle structure development | 1.988910e-4 |
GO:0032970 | regulation of actin filament-based process | 2.019799e-4 |
GO:0022600 | digestive system process | 2.030526e-4 |
GO:0009593 | detection of chemical stimulus | 2.196718e-4 |
GO:0045738 | negative regulation of DNA repair | 2.257107e-4 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 2.294526e-4 |
GO:0007606 | sensory perception of chemical stimulus | 2.389040e-4 |
GO:0010837 | regulation of keratinocyte proliferation | 2.393129e-4 |
GO:0031077 | post-embryonic camera-type eye development | 2.393129e-4 |
GO:0006749 | glutathione metabolic process | 2.438798e-4 |
GO:0007126 | meiosis | 2.451416e-4 |
GO:0051289 | protein homotetramerization | 2.513409e-4 |
GO:0070231 | T cell apoptosis | 2.557420e-4 |
GO:0051054 | positive regulation of DNA metabolic process | 2.605912e-4 |
GO:0051052 | regulation of DNA metabolic process | 2.813392e-4 |
GO:0090197 | positive regulation of chemokine secretion | 2.823388e-4 |
GO:0070252 | actin-mediated cell contraction | 2.863594e-4 |
GO:0060038 | cardiac muscle cell proliferation | 2.924269e-4 |
GO:0071480 | cellular response to gamma radiation | 3.009899e-4 |
GO:0002677 | negative regulation of chronic inflammatory response | 3.038265e-4 |
GO:0060978 | angiogenesis involved in coronary vascular morphogenesis | 3.112923e-4 |
GO:0033005 | positive regulation of mast cell activation | 3.256094e-4 |
GO:0048702 | embryonic neurocranium morphogenesis | 3.471714e-4 |
GO:0051403 | stress-activated MAPK cascade | 3.476114e-4 |
GO:0032269 | negative regulation of cellular protein metabolic process | 3.535436e-4 |
GO:0009791 | post-embryonic development | 3.878306e-4 |
GO:0001780 | neutrophil homeostasis | 4.045083e-4 |
GO:0033275 | actin-myosin filament sliding | 4.091577e-4 |
GO:0009615 | response to virus | 4.250778e-4 |
GO:0042744 | hydrogen peroxide catabolic process | 4.372417e-4 |
GO:0019307 | mannose biosynthetic process | 4.448831e-4 |
GO:0018158 | protein oxidation | 4.448831e-4 |
GO:0051321 | meiotic cell cycle | 4.582841e-4 |
GO:0031960 | response to corticosteroid stimulus | 4.754402e-4 |
GO:0060291 | long-term synaptic potentiation | 4.875282e-4 |
GO:0016052 | carbohydrate catabolic process | 4.988031e-4 |
GO:0042246 | tissue regeneration | 5.002346e-4 |
GO:0035051 | cardiac cell differentiation | 5.099608e-4 |
GO:0043922 | negative regulation by host of viral transcription | 5.234702e-4 |
GO:0072110 | glomerular mesangial cell proliferation | 5.265398e-4 |
GO:0007229 | integrin-mediated signaling pathway | 5.285322e-4 |
GO:0045347 | negative regulation of MHC class II biosynthetic process | 5.353881e-4 |
GO:0032231 | regulation of actin filament bundle assembly | 5.533878e-4 |
GO:0045616 | regulation of keratinocyte differentiation | 5.799692e-4 |
GO:0030316 | osteoclast differentiation | 5.852227e-4 |
GO:0033189 | response to vitamin A | 5.946029e-4 |
GO:0032897 | negative regulation of viral transcription | 5.969304e-4 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 6.000180e-4 |
GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 6.294719e-4 |
GO:0050428 | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process | 6.295864e-4 |
GO:0046164 | alcohol catabolic process | 6.301916e-4 |
GO:0009611 | response to wounding | 6.349983e-4 |
GO:0051795 | positive regulation of catagen | 6.387237e-4 |
GO:0032859 | activation of Ral GTPase activity | 6.387237e-4 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 6.387237e-4 |
GO:0019827 | stem cell maintenance | 6.982254e-4 |
GO:0008334 | histone mRNA metabolic process | 7.135188e-4 |
GO:0019318 | hexose metabolic process | 7.212525e-4 |
GO:0048844 | artery morphogenesis | 7.221860e-4 |
GO:0042440 | pigment metabolic process | 7.559257e-4 |
GO:0090196 | regulation of chemokine secretion | 7.696884e-4 |
GO:0030299 | intestinal cholesterol absorption | 7.701391e-4 |
GO:0061298 | retina vasculature development in camera-type eye | 7.701391e-4 |
GO:0015758 | glucose transport | 8.058163e-4 |
GO:0045073 | regulation of chemokine biosynthetic process | 8.291883e-4 |
GO:0046520 | sphingoid biosynthetic process | 8.443289e-4 |
GO:0009408 | response to heat | 8.477982e-4 |
GO:0055017 | cardiac muscle tissue growth | 8.615483e-4 |
GO:0035441 | cell migration involved in vasculogenesis | 8.890688e-4 |
GO:0014010 | Schwann cell proliferation | 8.890688e-4 |
GO:0051205 | protein insertion into membrane | 9.124337e-4 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 9.217007e-4 |
GO:0006928 | cellular component movement | 9.367448e-4 |
GO:0048524 | positive regulation of viral reproduction | 9.437880e-4 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 9.551358e-4 |
GO:0072277 | metanephric glomerular capillary formation | 9.551358e-4 |
GO:0032642 | regulation of chemokine production | 9.639670e-4 |
GO:0044275 | cellular carbohydrate catabolic process | 9.720196e-4 |
GO:0006014 | D-ribose metabolic process | 1.002690e-3 |
GO:0033003 | regulation of mast cell activation | 1.011368e-3 |
GO:0048569 | post-embryonic organ development | 1.027595e-3 |
GO:0009165 | nucleotide biosynthetic process | 1.076558e-3 |
GO:0021700 | developmental maturation | 1.092837e-3 |
GO:0002262 | myeloid cell homeostasis | 1.130922e-3 |
GO:0008645 | hexose transport | 1.220057e-3 |
GO:0044283 | small molecule biosynthetic process | 1.241554e-3 |
GO:0006754 | ATP biosynthetic process | 1.257380e-3 |
GO:0014003 | oligodendrocyte development | 1.319479e-3 |
GO:0030593 | neutrophil chemotaxis | 1.334094e-3 |
GO:0050900 | leukocyte migration | 1.347215e-3 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 1.404961e-3 |
GO:0046032 | ADP catabolic process | 1.404961e-3 |
GO:0046709 | IDP catabolic process | 1.404961e-3 |
GO:0009260 | ribonucleotide biosynthetic process | 1.407441e-3 |
GO:0042692 | muscle cell differentiation | 1.409780e-3 |
GO:0090285 | negative regulation of protein glycosylation in Golgi | 1.447647e-3 |
GO:0003008 | system process | 1.451851e-3 |
GO:0060613 | fat pad development | 1.473877e-3 |
GO:0046364 | monosaccharide biosynthetic process | 1.513611e-3 |
GO:0043269 | regulation of ion transport | 1.519924e-3 |
GO:0060415 | muscle tissue morphogenesis | 1.524296e-3 |
GO:0090273 | regulation of somatostatin secretion | 1.560866e-3 |
GO:0046501 | protoporphyrinogen IX metabolic process | 1.561820e-3 |
GO:0045684 | positive regulation of epidermis development | 1.576185e-3 |
GO:0006643 | membrane lipid metabolic process | 1.620655e-3 |
GO:0009395 | phospholipid catabolic process | 1.646449e-3 |
GO:0046031 | ADP metabolic process | 1.678561e-3 |
GO:0043306 | positive regulation of mast cell degranulation | 1.742297e-3 |
GO:0042060 | wound healing | 1.748040e-3 |
GO:0035404 | histone-serine phosphorylation | 1.771666e-3 |
GO:0010002 | cardioblast differentiation | 1.790970e-3 |
GO:0015749 | monosaccharide transport | 1.809353e-3 |
GO:0032787 | monocarboxylic acid metabolic process | 1.820003e-3 |
GO:0033002 | muscle cell proliferation | 1.842009e-3 |
GO:0044241 | lipid digestion | 1.931968e-3 |
GO:0043249 | erythrocyte maturation | 1.954738e-3 |
GO:0021629 | olfactory nerve structural organization | 2.005817e-3 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 2.005817e-3 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 2.005817e-3 |
GO:0060427 | lung connective tissue development | 2.005817e-3 |
GO:0006006 | glucose metabolic process | 2.027602e-3 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 2.087599e-3 |
GO:0007386 | compartment pattern specification | 2.087599e-3 |
GO:0051712 | positive regulation of killing of cells of other organism | 2.128761e-3 |
GO:0045617 | negative regulation of keratinocyte differentiation | 2.157567e-3 |
GO:0031069 | hair follicle morphogenesis | 2.159717e-3 |
GO:0045814 | negative regulation of gene expression, epigenetic | 2.191639e-3 |
GO:0031529 | ruffle organization | 2.214481e-3 |
GO:0055008 | cardiac muscle tissue morphogenesis | 2.251380e-3 |
GO:0006631 | fatty acid metabolic process | 2.308933e-3 |
GO:0032526 | response to retinoic acid | 2.322084e-3 |
GO:0060419 | heart growth | 2.371122e-3 |
GO:0031400 | negative regulation of protein modification process | 2.415345e-3 |
GO:0009607 | response to biotic stimulus | 2.467655e-3 |
GO:0034097 | response to cytokine stimulus | 2.470446e-3 |
GO:0035426 | extracellular matrix-cell signaling | 2.584258e-3 |
GO:0006066 | alcohol metabolic process | 2.711975e-3 |
GO:0051798 | positive regulation of hair follicle development | 2.730937e-3 |
GO:0034770 | histone H4-K20 methylation | 2.797649e-3 |
GO:0019376 | galactolipid catabolic process | 2.797649e-3 |
GO:0001701 | in utero embryonic development | 2.804117e-3 |
GO:0010561 | negative regulation of glycoprotein biosynthetic process | 2.807568e-3 |
GO:0031987 | locomotion involved in locomotory behavior | 2.807568e-3 |
GO:0034394 | protein localization at cell surface | 2.878618e-3 |
GO:0045623 | negative regulation of T-helper cell differentiation | 2.930087e-3 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 2.930087e-3 |
GO:0043302 | positive regulation of leukocyte degranulation | 2.930087e-3 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 3.086173e-3 |
GO:0060123 | regulation of growth hormone secretion | 3.097630e-3 |
GO:0046655 | folic acid metabolic process | 3.111015e-3 |
GO:0090276 | regulation of peptide hormone secretion | 3.168277e-3 |
GO:0035645 | enteric smooth muscle cell differentiation | 3.171568e-3 |
GO:0032929 | negative regulation of superoxide anion generation | 3.171568e-3 |
GO:0007497 | posterior midgut development | 3.171568e-3 |
GO:0002358 | B cell homeostatic proliferation | 3.171568e-3 |
GO:0002791 | regulation of peptide secretion | 3.210988e-3 |
GO:0032402 | melanosome transport | 3.217779e-3 |
GO:0045604 | regulation of epidermal cell differentiation | 3.232743e-3 |
GO:0046466 | membrane lipid catabolic process | 3.243447e-3 |
GO:0010591 | regulation of lamellipodium assembly | 3.303003e-3 |
GO:0007398 | ectoderm development | 3.303003e-3 |
GO:0051704 | multi-organism process | 3.318150e-3 |
GO:0050792 | regulation of viral reproduction | 3.341516e-3 |
GO:0048484 | enteric nervous system development | 3.360940e-3 |
GO:0009650 | UV protection | 3.447320e-3 |
GO:0002532 | production of molecular mediator involved in inflammatory response | 3.483895e-3 |
GO:0055085 | transmembrane transport | 3.488242e-3 |
GO:0022002 | negative regulation of anterior neural cell fate commitment of the neural plate by Wnt receptor signaling pathway | 3.651559e-3 |
GO:0002697 | regulation of immune effector process | 3.654912e-3 |
GO:0015074 | DNA integration | 3.676253e-3 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 3.715949e-3 |
GO:0021773 | striatal medium spiny neuron differentiation | 3.740402e-3 |
GO:0034653 | retinoic acid catabolic process | 3.914660e-3 |
GO:0019541 | propionate metabolic process | 3.914660e-3 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 3.985956e-3 |
GO:0006957 | complement activation, alternative pathway | 3.998481e-3 |
GO:0007565 | female pregnancy | 4.127519e-3 |
GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 4.291088e-3 |
GO:0042493 | response to drug | 4.310000e-3 |
GO:0072522 | purine-containing compound biosynthetic process | 4.405162e-3 |
GO:0046013 | regulation of T cell homeostatic proliferation | 4.406153e-3 |
GO:0009152 | purine ribonucleotide biosynthetic process | 4.417826e-3 |
GO:0014043 | negative regulation of neuron maturation | 4.434512e-3 |
GO:0008340 | determination of adult lifespan | 4.444550e-3 |
GO:0006408 | snRNA export from nucleus | 4.452324e-3 |
GO:0035745 | T-helper 2 cell cytokine production | 4.452324e-3 |
GO:0006048 | UDP-N-acetylglucosamine biosynthetic process | 4.452324e-3 |
GO:0051017 | actin filament bundle assembly | 4.467699e-3 |
GO:0007004 | telomere maintenance via telomerase | 4.577156e-3 |
GO:0016338 | calcium-independent cell-cell adhesion | 4.725652e-3 |
GO:0033273 | response to vitamin | 4.730875e-3 |
GO:0010716 | negative regulation of extracellular matrix disassembly | 4.779114e-3 |
GO:0014909 | smooth muscle cell migration | 4.779114e-3 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 4.781289e-3 |
GO:0051707 | response to other organism | 4.794123e-3 |
GO:0045348 | positive regulation of MHC class II biosynthetic process | 4.863840e-3 |
GO:0022607 | cellular component assembly | 4.940271e-3 |
GO:0009134 | nucleoside diphosphate catabolic process | 5.030240e-3 |
GO:0019319 | hexose biosynthetic process | 5.038400e-3 |
GO:0006164 | purine nucleotide biosynthetic process | 5.073880e-3 |
GO:0046898 | response to cycloheximide | 5.112523e-3 |
GO:0003007 | heart morphogenesis | 5.146579e-3 |
GO:0048644 | muscle organ morphogenesis | 5.188839e-3 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 5.188852e-3 |
GO:0009826 | unidimensional cell growth | 5.188852e-3 |
GO:0002376 | immune system process | 5.403611e-3 |
GO:0048864 | stem cell development | 5.521349e-3 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 5.585801e-3 |
GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation | 5.625317e-3 |
GO:0046148 | pigment biosynthetic process | 5.711507e-3 |
GO:0033629 | negative regulation of cell adhesion mediated by integrin | 5.775962e-3 |
GO:0010035 | response to inorganic substance | 5.778850e-3 |
GO:0042697 | menopause | 5.802676e-3 |
GO:0042167 | heme catabolic process | 5.802676e-3 |
GO:0018199 | peptidyl-glutamine modification | 5.802676e-3 |
GO:0006003 | fructose 2,6-bisphosphate metabolic process | 5.855890e-3 |
GO:0050434 | positive regulation of viral transcription | 6.084129e-3 |
GO:0045356 | positive regulation of interferon-alpha biosynthetic process | 6.125824e-3 |
GO:0042780 | tRNA 3'-end processing | 6.125824e-3 |
GO:0071780 | mitotic cell cycle G2/M transition checkpoint | 6.134786e-3 |
GO:0048870 | cell motility | 6.150408e-3 |
GO:0032501 | multicellular organismal process | 6.221612e-3 |
GO:0006955 | immune response | 6.241264e-3 |
GO:0060840 | artery development | 6.255115e-3 |
GO:0051607 | defense response to virus | 6.369238e-3 |
GO:0051208 | sequestering of calcium ion | 6.420193e-3 |
GO:0051355 | proprioception involved in equilibrioception | 6.420193e-3 |
GO:0046814 | virion attachment, binding of host cell surface coreceptor | 6.420193e-3 |
GO:2000657 | negative regulation of apolipoprotein binding | 6.420193e-3 |
GO:0090212 | negative regulation of establishment of blood-brain barrier | 6.420193e-3 |
GO:0019064 | viral envelope fusion with host membrane | 6.420193e-3 |
GO:0006409 | tRNA export from nucleus | 6.420193e-3 |
GO:0032621 | interleukin-18 production | 6.420193e-3 |
GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific | 6.420193e-3 |
GO:0048302 | regulation of isotype switching to IgG isotypes | 6.465079e-3 |
GO:0070498 | interleukin-1-mediated signaling pathway | 6.680294e-3 |
GO:0071478 | cellular response to radiation | 6.789474e-3 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 6.826286e-3 |
GO:2000774 | positive regulation of cellular senescence | 6.878777e-3 |
GO:0035986 | senescence-associated heterochromatin focus formation | 6.878777e-3 |
GO:0090402 | oncogene-induced senescence | 6.878777e-3 |
GO:0018209 | peptidyl-serine modification | 6.921648e-3 |
GO:0006958 | complement activation, classical pathway | 7.006927e-3 |
GO:0006476 | protein deacetylation | 7.107066e-3 |
GO:0019693 | ribose phosphate metabolic process | 7.136298e-3 |
GO:0032252 | secretory granule localization | 7.136298e-3 |
GO:0060389 | pathway-restricted SMAD protein phosphorylation | 7.152468e-3 |
GO:0060032 | notochord regression | 7.242050e-3 |
GO:0071712 | ER-associated misfolded protein catabolic process | 7.242050e-3 |
GO:0002352 | B cell negative selection | 7.242050e-3 |
GO:0030148 | sphingolipid biosynthetic process | 7.576072e-3 |
GO:0060437 | lung growth | 7.714925e-3 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 7.714925e-3 |
GO:0016572 | histone phosphorylation | 7.726250e-3 |
GO:0032648 | regulation of interferon-beta production | 7.786670e-3 |
GO:0051668 | localization within membrane | 7.801615e-3 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 7.866407e-3 |
GO:0031507 | heterochromatin formation | 7.886366e-3 |
GO:0034103 | regulation of tissue remodeling | 7.887992e-3 |
GO:0007586 | digestion | 7.937041e-3 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 8.165395e-3 |
GO:0010624 | regulation of Schwann cell proliferation | 8.165395e-3 |
GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein | 8.165395e-3 |
GO:0043031 | negative regulation of macrophage activation | 8.169961e-3 |
GO:0050760 | negative regulation of thymidylate synthase biosynthetic process | 8.169961e-3 |
GO:0006042 | glucosamine biosynthetic process | 8.169961e-3 |
GO:0042694 | muscle cell fate specification | 8.210825e-3 |
GO:0021675 | nerve development | 8.237348e-3 |
GO:0035590 | purinergic nucleotide receptor signaling pathway | 8.272429e-3 |
GO:0020027 | hemoglobin metabolic process | 8.314246e-3 |
GO:0048304 | positive regulation of isotype switching to IgG isotypes | 8.314246e-3 |
GO:0051146 | striated muscle cell differentiation | 8.615590e-3 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 8.739224e-3 |
GO:0042771 | DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis | 8.982269e-3 |
GO:0010038 | response to metal ion | 9.059323e-3 |
GO:0006665 | sphingolipid metabolic process | 9.126264e-3 |
GO:0071044 | histone mRNA catabolic process | 9.188341e-3 |
GO:0046394 | carboxylic acid biosynthetic process | 9.376753e-3 |
GO:0035601 | protein deacylation | 9.388774e-3 |
GO:0031109 | microtubule polymerization or depolymerization | 9.424006e-3 |
GO:0042168 | heme metabolic process | 9.452520e-3 |
GO:0048468 | cell development | 9.499917e-3 |
GO:0045087 | innate immune response | 9.513731e-3 |
GO:0042552 | myelination | 9.574004e-3 |
GO:0044262 | cellular carbohydrate metabolic process | 9.586239e-3 |
GO:0042363 | fat-soluble vitamin catabolic process | 9.670520e-3 |
GO:0035644 | phosphoanandamide dephosphorylation | 9.670520e-3 |
GO:0006787 | porphyrin-containing compound catabolic process | 9.670520e-3 |
GO:0008610 | lipid biosynthetic process | 9.729211e-3 |
GO:0072308 | negative regulation of metanephric nephron tubule epithelial cell differentiation | 9.812880e-3 |
GO:0071351 | cellular response to interleukin-18 | 9.812880e-3 |
GO:0060552 | positive regulation of fructose 1,6-bisphosphate metabolic process | 9.812880e-3 |
GO:0060550 | positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity | 9.812880e-3 |
GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 9.819484e-3 |
GO:0070301 | cellular response to hydrogen peroxide | 9.860792e-3 |
GO:0005975 | carbohydrate metabolic process | 1.000668e-2 |
GO:0072102 | glomerulus morphogenesis | 1.001125e-2 |
GO:0030857 | negative regulation of epithelial cell differentiation | 1.008699e-2 |
GO:0018130 | heterocycle biosynthetic process | 1.011634e-2 |
GO:0030225 | macrophage differentiation | 1.024018e-2 |
GO:0008088 | axon cargo transport | 1.026613e-2 |
GO:0045936 | negative regulation of phosphate metabolic process | 1.027072e-2 |
GO:0046467 | membrane lipid biosynthetic process | 1.040598e-2 |
GO:0008643 | carbohydrate transport | 1.042603e-2 |
GO:0042953 | lipoprotein transport | 1.045284e-2 |
GO:0070407 | oxidation-dependent protein catabolic process | 1.051345e-2 |
GO:0001775 | cell activation | 1.054344e-2 |
GO:0071288 | cellular response to mercury ion | 1.061444e-2 |
GO:0061301 | cerebellum vasculature morphogenesis | 1.061444e-2 |
GO:0046349 | amino sugar biosynthetic process | 1.061444e-2 |
GO:0051466 | positive regulation of corticotropin-releasing hormone secretion | 1.061444e-2 |
GO:0006812 | cation transport | 1.062092e-2 |
GO:0046426 | negative regulation of JAK-STAT cascade | 1.062699e-2 |
GO:0090343 | positive regulation of cell aging | 1.080872e-2 |
GO:0060051 | negative regulation of protein glycosylation | 1.083129e-2 |
GO:0019543 | propionate catabolic process | 1.083129e-2 |
GO:0044255 | cellular lipid metabolic process | 1.099121e-2 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 1.108454e-2 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 1.111001e-2 |
GO:0045080 | positive regulation of chemokine biosynthetic process | 1.111001e-2 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 1.117301e-2 |
GO:0006936 | muscle contraction | 1.118292e-2 |
GO:0090005 | negative regulation of establishment of protein localization in plasma membrane | 1.130581e-2 |
GO:0051891 | positive regulation of cardioblast differentiation | 1.137151e-2 |
GO:0046165 | alcohol biosynthetic process | 1.145651e-2 |
GO:0006260 | DNA replication | 1.191772e-2 |
GO:0035066 | positive regulation of histone acetylation | 1.199119e-2 |
GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway | 1.208522e-2 |
GO:0045767 | regulation of anti-apoptosis | 1.215193e-2 |
GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein | 1.224312e-2 |
GO:0046649 | lymphocyte activation | 1.233273e-2 |
GO:0006956 | complement activation | 1.264238e-2 |
GO:0043550 | regulation of lipid kinase activity | 1.283086e-2 |
GO:0003334 | keratinocyte development | 1.285517e-2 |
GO:0006925 | inflammatory cell apoptosis | 1.301350e-2 |
GO:0042326 | negative regulation of phosphorylation | 1.311774e-2 |
GO:0072014 | proximal tubule development | 1.312688e-2 |
GO:0071218 | cellular response to misfolded protein | 1.312688e-2 |
GO:0051030 | snRNA transport | 1.348546e-2 |
GO:0035633 | maintenance of blood-brain barrier | 1.348546e-2 |
GO:0048295 | positive regulation of isotype switching to IgE isotypes | 1.348546e-2 |
GO:0046034 | ATP metabolic process | 1.360580e-2 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 1.366953e-2 |
GO:0061013 | regulation of mRNA catabolic process | 1.376654e-2 |
GO:0008366 | axon ensheathment | 1.380779e-2 |
GO:0060601 | lateral sprouting from an epithelium | 1.385200e-2 |
GO:0042769 | DNA damage response, detection of DNA damage | 1.385200e-2 |
GO:0050715 | positive regulation of cytokine secretion | 1.385454e-2 |
GO:0042843 | D-xylose catabolic process | 1.406319e-2 |
GO:0042851 | L-alanine metabolic process | 1.406319e-2 |
GO:0015964 | diadenosine triphosphate catabolic process | 1.406319e-2 |
GO:0010760 | negative regulation of macrophage chemotaxis | 1.406319e-2 |
GO:0002158 | osteoclast proliferation | 1.406319e-2 |
GO:0031099 | regeneration | 1.413697e-2 |
GO:2000683 | regulation of cellular response to X-ray | 1.445419e-2 |
GO:0051904 | pigment granule transport | 1.445419e-2 |
GO:0035909 | aorta morphogenesis | 1.464436e-2 |
GO:0050877 | neurological system process | 1.464849e-2 |
GO:0002250 | adaptive immune response | 1.467745e-2 |
GO:0006575 | cellular modified amino acid metabolic process | 1.473779e-2 |
GO:0051045 | negative regulation of membrane protein ectodomain proteolysis | 1.476581e-2 |
GO:2000758 | positive regulation of peptidyl-lysine acetylation | 1.489974e-2 |
GO:0071479 | cellular response to ionizing radiation | 1.498098e-2 |
GO:0051583 | dopamine uptake | 1.514350e-2 |
GO:0071379 | cellular response to prostaglandin stimulus | 1.516940e-2 |
GO:0000103 | sulfate assimilation | 1.516940e-2 |
GO:0007010 | cytoskeleton organization | 1.517525e-2 |
GO:0061088 | regulation of sequestering of zinc ion | 1.547398e-2 |
GO:2000124 | regulation of endocannabinoid signaling pathway | 1.547398e-2 |
GO:0060049 | regulation of protein glycosylation | 1.547398e-2 |
GO:0046666 | retinal cell programmed cell death | 1.547398e-2 |
GO:0045079 | negative regulation of chemokine biosynthetic process | 1.547398e-2 |
GO:0002024 | diet induced thermogenesis | 1.547398e-2 |
GO:0045605 | negative regulation of epidermal cell differentiation | 1.557010e-2 |
GO:0042438 | melanin biosynthetic process | 1.557010e-2 |
GO:0090280 | positive regulation of calcium ion import | 1.566083e-2 |
GO:0006047 | UDP-N-acetylglucosamine metabolic process | 1.566083e-2 |
GO:0060252 | positive regulation of glial cell proliferation | 1.566083e-2 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.568648e-2 |
GO:0006954 | inflammatory response | 1.583707e-2 |
GO:0014041 | regulation of neuron maturation | 1.590242e-2 |
GO:0009888 | tissue development | 1.595054e-2 |